Cannabinoid exposure can cause lasting cognitive and psychiatric problems, especially in adolescents

Epidemiological and experimental evidence consistently links cannabis exposure to persistent cognitive deficits and increased psychosis risk, with adolescence as a critical vulnerability window.

Krebs, Marie-Odile et al.·European journal of pain (London·2019·Strong EvidenceNarrative Review
RTHC-02116Narrative ReviewStrong Evidence2019RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Narrative Review
Evidence
Strong Evidence
Sample
Not reported

What This Study Found

Cannabis use is associated with dose-dependent cognitive deficits and a 2-fold or greater increase in psychosis risk. THC produces transient psychotic symptoms in healthy humans that CBD can attenuate. Adolescent exposure in rodents causes structural brain changes and impaired synaptic plasticity in fronto-limbic systems that persist into adulthood.

Key Numbers

Cannabis use associated with approximately 2-fold increased risk of psychosis. Effects are modulated by dose, duration, age of first use, and genetic factors including shared genetic predisposition with schizophrenia.

How They Did This

Narrative review integrating epidemiological studies, experimental human studies with THC/CBD, and rodent adolescent exposure models, examining the endocannabinoid system's role in brain maturation.

Why This Research Matters

With cannabis legalization expanding, understanding who is most vulnerable to lasting harm is critical. This review marshals evidence from multiple research approaches pointing to adolescence as a particularly risky period.

The Bigger Picture

The endocannabinoid system plays a key role in brain maturation. Flooding it with external cannabinoids during development may permanently alter the trajectory of brain wiring, particularly in circuits responsible for higher-order thinking and emotional regulation.

What This Study Doesn't Tell Us

Narrative review without systematic methodology. Causality is difficult to establish from epidemiological data alone. Genetic confounders (shared predisposition to both cannabis use and psychosis) complicate interpretation.

Questions This Raises

  • ?Can genetic screening identify individuals most at risk before cannabis exposure?
  • ?Is there a safe age threshold below which all cannabis exposure carries developmental risk?

Trust & Context

Key Stat:
~2x psychosis risk
Evidence Grade:
Strong: consistent findings across epidemiological, experimental human, and animal studies from multiple research groups.
Study Age:
Published in 2019.
Original Title:
Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders.
Published In:
European journal of pain (London, England), 23(7), 1225-1233 (2019)
Database ID:
RTHC-02116

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research without a strict systematic method.

What do these levels mean? →

Frequently Asked Questions

Why are adolescents more vulnerable to cannabis effects?

The endocannabinoid system is actively involved in brain maturation during adolescence. Disrupting it with external cannabinoids like THC can alter the development of fronto-limbic circuits critical for cognition and emotional regulation.

Can CBD protect against THC's psychiatric effects?

Experimental studies in healthy humans showed that CBD can attenuate THC-induced psychotic symptoms and cognitive effects, though the protective extent in real-world use is not fully established.

Read More on RethinkTHC

Cite This Study

RTHC-02116·https://rethinkthc.com/research/RTHC-02116

APA

Krebs, Marie-Odile; Kebir, Oussama; Jay, Therese M. (2019). Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders.. European journal of pain (London, England), 23(7), 1225-1233. https://doi.org/10.1002/ejp.1377

MLA

Krebs, Marie-Odile, et al. "Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders.." European journal of pain (London, 2019. https://doi.org/10.1002/ejp.1377

RethinkTHC

RethinkTHC Research Database. "Exposure to cannabinoids can lead to persistent cognitive an..." RTHC-02116. Retrieved from https://rethinkthc.com/research/krebs-2019-exposure-to-cannabinoids-can

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.